Skip to main content

EC publishes Restrictions Roadmap

29th April 2022

Submitted by:

Andrew Warmington

The European Commission has published a Restrictions Roadmap under REACH, describing this as “an important step forward to provide detailed information on all ongoing work on future restrictions under the EU chemical legislation”.

Theroadmap prioritises group restrictions for the most harmful substances to human health and the environment, as set out in the Chemicals Strategy for Sustainability, which is itself part of the European Green Deal. It includes a rolling list of substances, which will become the basis for the multi-year planning under REACH, and will be updated regularly ahead of the planned revision of REACH in 2027.

The proposal is the first to focus on entire classes of chemical substances, something ECHA supports but industry generally dislikes. It is largely based on the draft circulated in 2021, and now also includes substances in food contact materials, single-use nappies and polycyclic aromatic hydrocarbons in granules for children playgrounds.

“EU chemical controls are usually achingly slow but the EU is planning the boldest detox we have ever seen,” said Tatiana Santos, chemicals policy manager at the European Environmental Bureau. “Petrochemical industry lobbyists are shocked at what is now on the table. It promises to improve the safety of almost all manufactured products and rapidly lower the chemical intensity of our schools, homes and workplaces.”

“Such restrictions may have significant impact on industry and value chains and consequently, on products produced and used in Europe,” CEFIC commented. However, it welcomed the roadmap’s promise of increased transparency on potential upcoming restrictions “as it provides us with foresight to prepare chemicals data like safety, toxicology, social-economic and alternatives”.

The association further called on the implementation process “to ensure clarity of scope, consider risks and impacts on value chains, all based on the latest scientific advancements” and a differentiated approach between industrial, professional and consumer uses of substances. Finally, it asked for more resources and expertise to be dedicated to supporting these changes, which will require considerable work by industry and the authorities, including ECHA.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Halozyme has dropped its approach to buy Evotec

Halozyme abandons Evotec bid

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington